Important Safety Information for GLP-1s At DirectCare.ai, your health and safety are our priority. Below is key safety information for GLP-1 medications, including Zepbound (tirzepatide), Ozempic (semaglutide), and compounded semaglutide.
Key Warnings: • Risk of Thyroid C-Cell Tumors: Studies in animals showed thyroid tumors, including cancer, with semaglutide and tirzepatide. It’s unknown if this risk applies to humans. Do not use these medications if you or a family member have had thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).• Serious Side Effects: Monitor for symptoms such as severe abdominal pain (possible pancreatitis), vision changes (retinopathy), or allergic reactions like swelling or difficulty breathing.• Not for Pregnancy: These medications should not be used during pregnancy due to potential risks to the unborn child.How to Use: • Administered as a once-weekly subcutaneous injection. Follow your provider’s instructions for dosage and administration.Common Side Effects: • Nausea, vomiting, diarrhea, constipation, and stomach pain are common but often improve with time.Consultation is Key: • Share your full medical history, including thyroid, kidney, or gallbladder conditions, and any current medications with your provider.
For Full Details: Visit the FDA’s MedWatch site for comprehensive prescribing information or consult with your DirectCare.ai provider for tailored guidance.Take control of your health with confidence. DirectCare.ai ensures safe, effective care every step of the way.
Policy Our goal is to provide safe, efficient, and reliable healthcare services that empower you to take control of your health.
Contact Us If you have questions about these Terms, please contact us: DirectCare.ai Email: [email protected]
